Crinetics Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on developing innovative treatments for rare endocrine diseases and endocrine-related tumors. The company boasts a diverse pipeline of therapeutic candidates designed to meet significant unmet medical needs within the endocrine disorder market, including both oral and targeted therapies. With a strong emphasis on research and development, Crinetics is well-positioned to lead advancements in specialized endocrine treatments, ultimately aiming to enhance patient outcomes and reshape treatment paradigms in this critical healthcare area.